Related Experiment Video
Updated: Jun 26, 2026

An Orthotopic Murine Model of Human Prostate Cancer Metastasis
Published on: September 18, 2013
Antigenotoxic effect of apigenin against mitomycin C induced genotoxic damage in mice bone marrow cells
Yasir Hasan Siddique1, Mohammad Afzal
1Human Genetics and Toxicology Lab, Section of Genetics, Department of Zoology, Faculty of Life Sciences, Aligarh Muslim University, Aligarh, U.P. 202 002, India. yasir_hasansiddique@rediffmail.com
Abstract:
The antigenotoxic effect of apigenin was studied against the genotoxic damage induced by mitomycin C on mouse bone marrow cells using sister chromatid exchanges (SCEs) and chromosomal aberrations (CAs) as parameters. Apigenin was studied at three different doses i.e. 10, 20 and 40 mg/kg b.w. and was found to be non-genotoxic at all the above three doses. Mitomycin C at 2 mg/kg b.w. was given along with the 10, 20 and 40 mg/kg bw of apigenin. A significant decrease in SCEs and CAs was observed, suggesting a protective role of apigenin against the genotoxicity of mitomycin C on mice bone marrow cells.
Insights
Apigenin demonstrated antigenotoxic effects, protecting mouse bone marrow cells from mitomycin C-induced damage. This study found apigenin significantly reduced sister chromatid exchanges and chromosomal aberrations, indicating a protective role.
Area of Science:
- Toxicology
- Genetics
- Pharmacology
Background:
- Genotoxicity poses a significant health risk.
- Mitomycin C is a known genotoxic agent.
- Apigenin is a natural flavonoid with potential therapeutic properties.
Purpose of the Study:
- To investigate the antigenotoxic potential of apigenin.
- To evaluate apigenin's protective effects against mitomycin C-induced genotoxicity.
- To assess apigenin's safety at tested doses.
Main Methods:
- Assessing sister chromatid exchanges (SCEs) and chromosomal aberrations (CAs) in mouse bone marrow cells.
- Administering apigenin at doses of 10, 20, and 40 mg/kg body weight.
- Co-administering mitomycin C (2 mg/kg body weight) with apigenin.
Main Results:
- Apigenin was found to be non-genotoxic at all tested doses.
- A significant reduction in SCEs and CAs was observed when apigenin was co-administered with mitomycin C.
- Apigenin demonstrated a protective effect against mitomycin C-induced genotoxicity.
Conclusions:
- Apigenin exhibits significant antigenotoxic properties.
- Apigenin can protect against mitomycin C-induced genotoxicity in mouse bone marrow cells.
- Apigenin is a promising candidate for further investigation as a chemoprotective agent.
More Related Videos
10:14Detection of Inter-chromosomal Stable Aberrations by Multiple Fluorescence In Situ Hybridization (mFISH) and Spectral Karyotyping (SKY) in Irradiated Mice
Published on: January 11, 2017
11:24Measuring DNA Damage and Repair in Mouse Splenocytes After Chronic In Vivo Exposure to Very Low Doses of Beta- and Gamma-Radiation
Published on: July 3, 2015
Related Concept Videos
Mutagenicity and Carcinogenicity
Mouse Models of Cancer Study
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...